KROLL MARK W 4
4 · HAEMONETICS CORP · Filed May 28, 2021
Insider Transaction Report
Form 4
KROLL MARK W
Director
Transactions
- Exercise/Conversion
Common Stock
2021-05-26$35.50/sh+10,353$367,557→ 30,253 total - Sale
Common Stock
2021-05-26$55.10/sh−11,813$650,896→ 18,440 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2021-05-26−10,353→ 0 totalExercise: $35.50From: 2015-07-24Exp: 2021-07-23→ Common Stock (10,353 underlying)
Footnotes (3)
- [F1]The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Option vests 100% on the first anniversary of the date of grant.